Back    Zoom +    Zoom -
ALI HEALTH, Novartis Forge Digital Chronic Disease Partnership
Recommend
1
Positive
7
Negative
0
aacat by AASTOCKS
Open a new trading account to get TENCENT shares!
ALI HEALTH (00241.HK) and Novartis announced a digital chronic disease partnership in the field of Chronic Spontaneous Urticaria (CSU).

Both parties will focus on Novartis's global first oral targeted urticaria drug, and leverage Alibaba Health's digital platform capabilities to provide integrated services ranging from disease education and medication guidance to full-cycle health management.
AASTOCKS Financial News
Website: www.aastocks.com
  • Remark
  • (1) HK Indices are real time
Home|RT Quote|Market|News|Indices
Feedback|Disclaimer
View: Mobile|Desktop
Lang: 繁|简|EN
Back To Top
Contact Us
Email: support@aastocks.com